1. Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytes
   YU SAWADA et al, 2015, International Journal of Oncology CrossRef
2. Engineering α-fetoprotein-based Gene Vaccines to Prevent and Treat Hepatocellular Carcinoma: Review and Future Prospects
   Yukai He et al, 2014, Immunotherapy CrossRef
3. Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma
   Li Wang et al, 2015, Hepatobiliary & Pancreatic Diseases International CrossRef
4. Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses
   Bingfeng Zuo et al, 2022, Journal of Hematology & Oncology CrossRef
5. Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment
   Fubo Zhou et al, 2018, Medicinal Research Reviews CrossRef
6. Efficacy of immunotherapy targeting the neoantigen derived from epidermal growth factor receptor T790M/C797S mutation in non–small cell lung cancer
   Yu Akazawa et al, 2020, Cancer Science CrossRef
7. Tumor Microenvironment: Extracellular Matrix Alterations Influence Tumor Progression
   Sylvie Brassart-Pasco et al, 2020, Frontiers in Oncology CrossRef
8. Plasmodium parasite as an effective hepatocellular carcinoma antigen glypican-3 delivery vector
   Quan Liu et al, 2017, Oncotarget CrossRef
9. Enhancement of antitumor effect by peptide vaccine therapy in combination with anti-CD4 antibody: Study in a murine model
   Norihiro Fujinami et al, 2016, Biochemistry and Biophysics Reports CrossRef
10. Prediction and preliminary screening of HLA‐A*0201‐restricted epitope peptides of human GPC3
    P. Hu et al, 2016, International Journal of Immunogenetics CrossRef
11. Fragments generated upon extracellular matrix remodeling: Biological regulators and potential drugs
    Sylvie Ricard-Blum et al, 2019, Matrix Biology CrossRef
12. Analysis of cytotoxic T lymphocytes from a patient with hepatocellular carcinoma who showed a clinical response to vaccination with a glypican-3-derived peptide
    YOSHITAKA TADA et al, 2013, International Journal of Oncology CrossRef
13. Vaccination with liposome-coupled glypican-3-derived epitope peptide stimulates cytotoxic T lymphocytes and inhibits GPC3-expressing tumor growth in mice
    Tatsuaki Iwama et al, 2016, Biochemical and Biophysical Research Communications CrossRef
14. A Novel Vaccine Targeting Glypican-3 as a Treatment for Hepatocellular Carcinoma
    Qunfeng Wu et al, 2017, Molecular Therapy CrossRef